Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e22447
Publisher
Public Library of Science (PLoS)
Online
2011-08-23
DOI
10.1371/journal.pone.0022447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
- (2014) M Rodgers et al. HEALTH TECHNOLOGY ASSESSMENT
- Body mass index and clinical response to infliximab in rheumatoid arthritis
- (2010) Ruth Klaasen et al. ARTHRITIS AND RHEUMATISM
- Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death
- (2010) Katrin Anne Becker et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients
- (2010) G. V. Coppa et al. GLYCOBIOLOGY
- Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I
- (2010) Mark J Osborn et al. MOLECULAR THERAPY
- Mucopolysaccharidosis VI
- (2010) Vassili Valayannopoulos et al. Orphanet Journal of Rare Diseases
- Ultrastructural Analysis of Dermal Fibroblasts in Mucopolysaccharidosis Type I: Effects of Enzyme Replacement Therapy and Hematopoietic Cell Transplantation
- (2010) Josanne Cox-Brinkman et al. ULTRASTRUCTURAL PATHOLOGY
- Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study
- (2009) JJ McGill et al. CLINICAL GENETICS
- Different Serum Enzyme Levels Are Required to Rescue the Various Systemic Features of the Mucopolysaccharidoses
- (2009) Gabriella Cotugno et al. HUMAN GENE THERAPY
- Mechanism of shortened bones in mucopolysaccharidosis VII
- (2009) Jason A. Metcalf et al. MOLECULAR GENETICS AND METABOLISM
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression
- (2009) Victoria Connor RHEUMATOLOGY INTERNATIONAL
- The mucopolysaccharidoses: a success of molecular medicine
- (2008) Lorne A. Clarke EXPERT REVIEWS IN MOLECULAR MEDICINE
- Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy
- (2008) Ramin Sedaghat Herati et al. MOLECULAR GENETICS AND METABOLISM
- Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease
- (2007) Calogera M. Simonaro et al. AMERICAN JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started